AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Conversations from CROI 2015: CDC’s Dr. John Ward on Hepatitis C

IMG_7021

i Hepatitis C was in the spotlight last week at the 2015 Conference on Retroviruses and Opportunistic Infections  (CROI) in Seattle. So Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, spoke with Dr. John Ward, Director of CDC’s Division of Viral Hepatitis about some of the key science findings being discussed as well as…

Scientific Advances in HIV and HCV To Be Examined Next Week at CROI 2015

AIDS.gov

The 2015 Conference on Retroviruses and Opportunistic Infections (CROI)   takes place next week in Seattle, Washington, and AIDS.gov will be there. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS, hepatitis C (HCV), Ebola, and related infectious diseases provides a vital forum for translating laboratory and clinical research into…

PCORI Announces $50 million in Hepatitis C Research Funding

AIDS.gov

Hepatitis C virus (HCV) research recently received a significant boost with a commitment of up to $50 million in funding from the Patient-Centered Outcomes Research Institute  (PCORI) for comparative clinical effectiveness research (CER) studies on the best ways to diagnose and treat HCV infection.  PCORI posted application materials  earlier this month and announced a May…

Call for Abstracts: 2015 National Summit on HCV and HIV Diagnosis, Prevention, and Access to Care

2015_NSummit2015_LOGO_web

The 2015 National Summit on HCV and HIV Diagnosis, Prevention, and Access to Care is seeking abstract submissions. Scheduled for June 4-6, 2015 in Arlington, Virgini a, the mission of the Summit is to support improvement in HCV and HIV testing, prevention, and linkage to care in the United States. Participants from the nation’s public…

CDC Launches Next Phase of Know More Hepatitis Campaign

KMG_Logo

CDC has just released the next phase of the national Know More Hepatitis campaign. Of the estimated 3.2 million Americans who have Hepatitis C, 3 in 4 are people born from 1945 to 1965. Since as many as 50% of people with Hepatitis C don’t know they are infected, the campaign encourages everyone born from…

A Post from the ADAP Crisis Task Force

AIDS.gov

ADAP Crisis Task Force Announces Groundbreaking Agreement with AbbVie for Hepatitis C Treatment Viekira Pak ™ FOR IMMEDIATE RELEASE Contact:  Britten Pund 202-434-8090 bpund@NASTAD.org  January 15, 2015, Washington, DC – The ADAP Crisis Task Force (Task Force) has reached a new pricing agreement between AbbVie and AIDS Drug Assistance Programs (ADAPs) for Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets;…

Report of 2013 Progress on Viral Hepatitis Action Plan

V

This week, we release the third annual report of progress made in implementing the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis (Action Plan). The 2013 report [PDF 655KB], compiled by the HHS Office of HIV/AIDS and Infectious Disease Policy, spotlights several key accomplishments under each of the Action Plan’s six priority areas…

NIH Announces Funding for New Technologies for Viral Hepatitis

nih logo

The National Institutes of Health (NIH) has issued a funding opportunity announcement (FOA) to encourage small businesses to address viral hepatitis research opportunities delineated in the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis (Action Plan) [PDF 2MB]. The announcement of a Small Business Innovation Research (SBIR) grant entitled New Technologies for Viral…